» Articles » PMID: 10810297

Optimisation of Growth Hormone Production by Muscle Cells Using Plasmid DNA

Overview
Journal J Endocrinol
Specialty Endocrinology
Date 2000 May 16
PMID 10810297
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The production of peptide hormones by skeletal muscle tissue is a promising area of gene therapy. Skeletal muscle myogenesis can be induced in vitro, resulting in the fusion of mononucleate myoblasts to form multinucleate myotubes, and delivery vectors are first tested in vitro. C2C12 myoblasts transfected with pcDNA3-GH, which used the human cytomegalovirus (CMV) promoter, secreted immunoreactive GH with comparable biological activity to pituitary GH. Mouse myeloid leukaemia cells, which express the mouse GH receptor were used for the bioassay, and activation of these cells by GH was measured by a colorimetric microculture tetrazolium assay. Cells were incubated with a tetrazolium salt (MTS) and an intermediate electron acceptor (phenazine methosulphate, PMS), and formazan production was measured as optical density (O.D.) at 490 nm. The efficiencies of several plasmid expression vectors were compared in differentiated and non-differentiated muscle cells, as a function of bioactive GH secreted by the transfected cells. Ten-day differentiated C2C12 myotubes transfected with pcDNA3E-GH, which used the CMV promoter and a rat myosin light chain enhancer element, secreted significantly more biologically active GH than myotubes transfected with pcDNA3-GH (0.82 O.D. units+/-0.06 vs 0.57+/-0.05 respectively, P<0.001). This was consistent with reduced CMV promoter activity in myotubes. Myoblasts transfected with pcDNA3-GH secreted more bioactive GH than 10-day transfected myotubes (1.1+/-0. 1 vs 0.77+/-0.07 respectively). However, the responses were indistinguishable (both 1.0+/-0.09) if both the myotubes and myoblasts had been transfected with pcDNA3E-GH. Substitution of the vector pMHLC-GH, which used a muscle-specific truncated rabbit myosin heavy chain promoter, and the myosin enhancer resulted in a marked decrease in the responses to the conditioned medium from fused myotubes compared with the vectors pcDNA3-GH and pcDNA3E-GH (0. 24+/-0.02 vs 0.57+/-0.05 vs 0.82+/-0.06 respectively). We concluded that the combination of CMV promoter and myosin light chain enhancer in pcDNA3E-GH had the greatest expression efficiency of the several plasmid vectors which we investigated.

Citing Articles

Virus-free transfection, transient expression, and purification of human cardiac myosin in mammalian muscle cells for biochemical and biophysical assays.

Velayuthan L, Moretto L, Tagerud S, Usaj M, Mansson A Sci Rep. 2023; 13(1):4101.

PMID: 36907906 PMC: 10008826. DOI: 10.1038/s41598-023-30576-1.


A Muscle Hybrid Promoter as a Novel Tool for Gene Therapy.

Piekarowicz K, Bertrand A, Azibani F, Beuvin M, Julien L, Machowska M Mol Ther Methods Clin Dev. 2019; 15:157-169.

PMID: 31660418 PMC: 6807297. DOI: 10.1016/j.omtm.2019.09.001.


An adeno-associated virus vector efficiently and specifically transduces mouse skeletal muscle.

Murakami I, Takeuchi T, Mori-Uchino M, Mori S, Fujii T, Aoki D Mol Biotechnol. 2011; 49(1):1-10.

PMID: 21197588 DOI: 10.1007/s12033-010-9369-z.


Enhanced muscle growth by plasmid-mediated delivery of myostatin propeptide.

Hu S, Chen C, Sheng J, Sun Y, Cao X, Qiao J J Biomed Biotechnol. 2010; 2010:862591.

PMID: 20300438 PMC: 2840606. DOI: 10.1155/2010/862591.


IGF1 gene transfer into skeletal muscle using recombinant adeno-associated virus in a rat model of liver cirrhosis.

Zaratiegui M, Castilla-Cortazar I, Garcia M, Quiroga J, Prieto J, Novo F J Physiol Biochem. 2003; 58(3):169-76.

PMID: 12603011 DOI: 10.1007/BF03179854.